Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 55 Records) |
Query Trace: Mantle Cell Lymphoma[original query] |
---|
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab. British journal of haematology 2018 Sep . Cencini Emanuele, Sicuranza Anna, Fabbri Alberto, Ferrigno Ilaria, Rigacci Luigi, Cox Maria C, Raspadori Donatella, Bocchia Moni |
TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma. Clinical lymphoma, myeloma & leukemia 2018 8 18 (11): 762-768. Obr Aleš, Procházka Vít, Jirkuvová Andrea, Urbánková Helena, Kriegova Eva, Schneiderová Petra, Vatolíková Michaela, Papajík Tom |
Genomic landscape and prognostic analysis of mantle cell lymphoma. Cancer gene therapy 2018 May . Yang Ping, Zhang Weilong, Wang Jing, Liu Yuanyuan, An Ran, Jing Hongm |
Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma. Blood advances 2018 3 2 (6): 621-625. Wasik Agata M, Wu Chenglin, Mansouri Larry, Rosenquist Richard, Pan-Hammarström Qiang, Sander Birgit |
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. Haematologica 2019 9 105 (6): 1604-1612. Ferrero Simone, Rossi Davide, Rinaldi Andrea, Bruscaggin Alessio, Spina Valeria, Eskelund Christian W, Evangelista Andrea, Moia Riccardo, Kwee Ivo, Dahl Christina, Di Rocco Alice, Stefoni Vittorio, Diop Fary, Favini Chiara, Ghione Paola, Mahmoud Abdurraouf Mokhtar, Schipani Mattia, Kolstad Arne, Barbero Daniela, Novero Domenico, Paulli Marco, Zamò Alberto, Jerkeman Mats, da Silva Maria Gomes, Santoro Armando, Molinari Annalia, Ferreri Andres, Grønbæk Kirsten, Piccin Andrea, Cortelazzo Sergio, Bertoni Francesco, Ladetto Marco, Gaidano Gianlu |
Mantle Cell Lymphoma: Which Patients Should We Transplant? Current hematologic malignancy reports 2019 6 14 (4): 239-246. Gerson James N, Barta Stefan |
The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population. Leukemia & lymphoma 2019 6 60 (12): 2899-2908. Zhong Charlie, Gragert Loren, Maiers Martin, Hill Brian T, Garcia-Gomez Jean, Gendzekhadze Ketevan, Senitzer David, Song Joo, Weisenburger Dennis, Goldstein Leanne, Wang Sophia |
A high mutation rate of immunoglobulin heavy chain variable region gene associates with a poor survival and chemotherapy response of mantle cell lymphoma patients. Medicine 2019 May 98 (22): e15811. Li Xianqian, Wu Ning, Li B |
TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant. Annals of diagnostic pathology 2019 5 41 38-42. Sakhdari Ali, Ok Chi Young, Patel Keyur P, Kanagal-Shamanna Rashmi, Yin C Cameron, Zuo Zhuang, Hu Shimin, Routbort Mark J, Luthra Rajyalakshmi, Medeiros L Jeffrey, Khoury Joseph D, Loghavi San |
ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. Leukemia & lymphoma 2019 Jan 1-9. Mareckova Andrea, Malcikova Jitka, Tom Nikola, Pal Karol, Radova Lenka, Salek David, Janikova Andrea, Moulis Mojmir, Smardova Jana, Kren Leos, Mayer Jiri, Trbusek Mart |
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study. Scientific reports 2020 Aug 10 (1): 13359. Jeong Seri, Park Yu Jin, Yun Woobin, Lee Seung-Tae, Choi Jong Rak, Suh Cheolwon, Jo Jae-Cheol, Cha Hee Jeong, Jeong Jee-Yeong, Chang HeeKyung, Cha Yoon Jin, Kim Hyerim, Park Min-Jeong, Song Wonkeun, Cho Eun-Hae, Jeong Eun-Goo, Lee Junnam, Park Yongmin, Lee Yong Seok, Kim Da Jung, Lee Ho S |
Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. Genes, chromosomes & cancer 2020 4 59 (8): 484-494. Streich Lukas, Sukhanova Madina, Lu Xinyan, Chen Yi-Hua, Venkataraman Girish, Mathews Stephanie, Zhang Shanxiang, Kelemen Katalin, Segal Jeremy, Gao Juehua, Gordon Leo, Chen Qing, Behdad Am |
Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma. Translational oncology 2020 3 13 (3): 100744. Annese Tiziana, Ingravallo Giuseppe, Tamma Roberto, De Giorgis Michelina, Maiorano Eugenio, Perrone Tommasina, Albano Francesco, Specchia Giorgina, Ribatti Domeni |
Germline variants of DNA repair genes in early onset mantle cell lymphoma. Oncogene 2020 11 40 (3): 551-563. Wang Xiaogan, Song Yuqin, Chen Wei, Ding Ning, Liu Weiping, Xie Yan, Wang Yinan, Zhu Jun, Zeng Changqi |
LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies. The Journal of molecular diagnostics : JMD 2021 6 23 (8): 959-974. Navrkalova Veronika, Plevova Karla, Hynst Jakub, Pal Karol, Mareckova Andrea, Reigl Tomas, Jelinkova Hana, Vrzalova Zuzana, Stranska Kamila, Pavlova Sarka, Panovska Anna, Janikova Andrea, Doubek Michael, Kotaskova Jana, Pospisilova Sar |
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets. Leukemia & lymphoma 2021 6 62 (11): 2637-2647. Rodrigues Joana M, Porwit Anna, Hassan May, Ek Sara, Jerkeman Ma |
Loncastuximab Tesirine: First Approval. Drugs 2021 . Lee Arno |
Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma. BMC cancer 2021 3 21 (1): 209. Assis-Mendonça Guilherme Rossi, Fattori André, Rocha Rafael Malagoli, Lourenço Gustavo Jacob, Delamain Márcia Torresan, Nonogaki Suely, de Lima Vladmir Cláudio Cordeiro, Colleoni Gisele Wally Braga, de Souza Cármino Antonio, Soares Fernando Augusto, Lima Carmen Silvia Passos, Vassallo Jo |
Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. Cancer science 2022 9 113 (11): 3972-3979. Usui Yoshiaki, Iwasaki Yusuke, Matsuo Keitaro, Endo Mikiko, Kamatani Yoichiro, Hirata Makoto, Sugano Kokichi, Yoshida Teruhiko, Matsuda Koichi, Murakami Yoshinori, Maeda Yoshinobu, Nakagawa Hidewaki, Momozawa Yukihi |
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma. Oncotarget 2022 9 13 986-1002. LeBlanc Francis R, Hasanali Zainul S, Stuart August, Shimko Sara, Sharma Kamal, Leshchenko Violetta V, Parekh Samir, Fu Haiqing, Zhang Ya, Martin Melvenia M, Kester Mark, Fox Todd, Liao Jiangang, Loughran Thomas P, Evans Juanita, Pu Jeffrey J, Spurgeon Stephen E, Aladjem Mirit I, Epner Elliot |
Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers. British journal of haematology 2022 8 199 (3): 371-381. Petrackova Anna, Savara Jakub, Turcsanyi Peter, Gajdos Petr, Papajik Tomas, Kriegova E |
Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[F]-FDG PET/CT in Elderly Mantle Cell Lymphoma. Journal of clinical medicine 2022 3 11 (5): . Albano Domenico, Pasinetti Nadia, Dondi Francesco, Giubbini Raffaele, Tucci Alessandra, Bertagna Frances |
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 1 40 (11): 1196-1205. Giné Eva, de la Cruz Fátima, Jiménez Ubieto Ana, López Jimenez Javier, Martín García-Sancho Alejandro, Terol M José, González Barca Eva, Casanova María, de la Fuente Adolfo, Marín-Niebla Ana, Muntañola Ana, González-López Tomás José, Aymerich Marta, Setoain Xavier, Cortés-Romera Montserrat, Rotger Amanda, Rodríguez Sonia, Medina Herrera Alejandro, García Sanz Ramón, Nadeu Ferran, Beà Silvia, Campo Elías, López-Guillermo Arman |
Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma. Leukemia & lymphoma 2023 9 1-11. Andrew Ip, Alessandra Petrillo, Alexandra Della Pia, Geeny G Lee, Sarvarinder Gill, Tony Varughese, Joshua Zenreich, Martin Gutierrez, Jiayu Zhang, Jaeil Ahn, Vishnu Bharani, Ava S Nejad, Lauren Pascual, Tatyana A Feldman, Lori A Leslie, Andre H G |
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study. Leukemia & lymphoma 2023 7 1-9. Emanuele Cencini, Anna Sicuranza, Alberto Fabbri, Cristina Marzano, Paola Pacelli, Federico Caroni, Donatella Raspadori, Monica Bocch |
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the FIL MCL0208 trial. Blood advances 2023 4 . Ferrero Simone, Grimaldi Daniele, Arrigoni Elena, Pironti Mariapia, Zaccaria Gian Maria, Alessandria Beatrice, Genuardi Elisa, De Luca Gabriele, Ghislieri Marco, Tavarozzi Rita, Di Rocco Alice, Re Alessandro, Stefoni Vittorio, Cavallo Federica, Boccomini Carola, Balzarotti Monica, Zilioli Vittorio Ruggero, Moita Filipa, Arcaini Luca, Lucchini Elisa, Ballerini Filippo, Ferreri Andrés J M, Puccini Benedetta, Palumbo Giuseppe A, Galimberti Sara, Cortelazzo Sergio, Di Paolo Antonello, Ladetto Mar |
MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of clinical medicine 2023 4 12 (7): . Mu Yafei, Fan Xijie, Chen Tao, Meng Yuhuan, Lin Junwei, Yuan Jiecheng, Yu Shihui, Chen Yuxin, Liu Lingli |
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group. Haematologica 2023 11 . Sylvain Carras, Alexia Torroja, Anouk Emadali, Emilie Montaut, Nicolas Daguindau, Adrian Tempescul, Anne Moreau, Emmanuelle Tchernonog, Anna Schmitt, Roch Houot, Caroline Dartigeas, Sarah Barbieux, Selim Corm, Anne Banos, Ludovic Fouillet, Jehan Dupuis, Margaret Macro, Joel Fleury, Fabrice Jardin, Clementine Sarkozy, Ghandi Damaj, Pierre Feugier, Luc Matthieu Fornecker, Cecile Chabrot, Veronique Dorvaux, Krimo Bouabdallah, Sandy Amorim, Reda Garidi, Laurent Voillat, Bertrand Joly, Nadine Morineau, Marie Pierre Moles, Hacene Zerazhi, Jean Fontan, Yazid Arkam, Magda Alexis, Vincent Delwail, Jean Pierre Vilque, Loic Ysebaert, Barbara Burroni, Mary Callanan, Steven Le Gouill, Rémy Gress |
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine 2023 10 64 102221. Urban Novak, Martin Fehr, Sämi Schär, Martin Dreyling, Christian Schmidt, Enrico Derenzini, Thilo Zander, Georg Hess, Ulrich Mey, Simone Ferrero, Nicolas Mach, Carola Boccomini, Sebastian Böttcher, Michèle Voegeli, Anne Cairoli, Vanesa-Sindi Ivanova, Thomas Menter, Stefan Dirnhofer, Bernhard Scheibe, Sandra Gadient, Katrin Eckhardt, Emanuele Zucca, Christoph Driessen, Christoph Renn |
Genetic and prognostic analysis of blastoid and pleomorphic mantle cell lymphoma: a multicenter analysis in China. Annals of hematology 2024 1 . Ping Yang, Shuo-Zi Liu, Chun-Yuan Li, Wei-Long Zhang, Jing Wang, Ying-Tong Chen, Sen Li, Cui-Ling Liu, Hui Liu, Qing-Qing Cai, Wei Zhang, Hong-Mei Ji |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: